Prosecution Insights
Last updated: November 20, 2026
Application No. 18/708,305

FILM QUALITY IMPROVER, METHOD OF FORMING THIN FILM USING FILM QUALITY IMPROVER, SEMICONDUCTOR SUBSTRATE FABRICATED USING METHOD, AND SEMICONDUCTOR DEVICE INCLUDING SEMICONDUCTOR SUBSTRATE

Final Rejection §102§103§112§DOUBLEPATENT
Filed
May 08, 2024
Priority
Nov 25, 2021 — RE 10-2021-0164643 +2 more
Examiner
LAW, NGA LEUNG V
Art Unit
1717
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Soulbrain Co., Ltd.
OA Round
4 (Final)
56%
Grant Probability
Moderate
5-6
OA Rounds
8m
Est. Remaining
75%
With Interview

Examiner Intelligence

Grants 56% of resolved cases
56%
Career Allowance Rate
314 granted / 558 resolved
-8.7% vs TC avg
Strong +18% interview lift
Without
With
+18.3%
Interview Lift
resolved cases with interview
Typical timeline
3y 2m
Avg Prosecution
40 currently pending
Career history
612
Total Applications
across all art units

Statute-Specific Performance

§101
1.0%
-39.0% vs TC avg
§103
59.7%
+19.7% vs TC avg
§102
9.3%
-30.7% vs TC avg
§112
25.9%
-14.1% vs TC avg
Black line = Tech Center average estimate • Based on career data from 558 resolved cases

Office Action

§102 §103 §112 §DOUBLEPATENT
DETAILED ACTION The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . The Applicant's amendment filed on August 14, 2026 was received. Claims 6 and 14 were amended. Claims 1-5 and 9-10 were canceled. Claims 11-13 were withdrawn. No claim was added. The text of those sections of Title 35. U.S.C. code not included in this action can be found in the prior Office Action Issued on June 17, 2026. Claim Objections Claims 6-8 and 14-16 are objected to because of the following informalities: Claim 6, line 6, “Chemical Formulas 2 to 39” should be corrected to “Chemical Formulas 2 to 36”. Claim 6, lines 6-7, “a precursor compound for molybdenum-based thin films” should be corrected to “a molybdenum precursor”’; and step iii-a), “a molybdenum precursor” should be corrected to “the molybdenum precursor”. Claim 6, after step vii), “wherein the molybdenum-based thin film….on a substrate” should be corrected to “wherein the molybdenum-based thin film….on the substrate”. Claims 6, each one of the chemical formulas 2 to 36, should be clearly labeled by number, for example PNG media_image1.png 174 356 media_image1.png Greyscale . Claim 7, “the thin film is an oxide film, a nitride film or a metal film” should be corrected to “the molybdenum-based thin film is molybdenum metal, molybdenum oxide or molybdenum nitride” so that the limitation is consistent with claim 6. Claim 14, step i-b), should include “selected from Chemical Formulas 2 to 36” when describing “a molybdenum precursor”. Claim 14, line 10, “Chemical Formulas 2-39” should be corrected to “Chemical Formulas 2 to 36”. Claim 14, line 10, “a precursor compound for molybdenum-based thin films” should be corrected to “the molybdenum precursor”. Claim 14, after step vii), “wherein the molybdenum-based thin film….on a substrate” should be corrected to “wherein the molybdenum-based thin film….on the substrate”. Claim 14, each one of the chemical formulas 2 to 36, should be clearly labeled by number, for example PNG media_image1.png 174 356 media_image1.png Greyscale . Claim 15, “the thin film is an oxide film, a nitride film or a metal film” should be corrected to “the molybdenum-based thin film is molybdenum metal, molybdenum oxide or molybdenum nitride” so that the limitation is consistent with claim 14. Appropriate correction is required. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 6-8 and 14-16 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. Regarding claim 6, while the claim defines the film quality improver being a saturated compound represented by Chemical Formula 1, it also defines that the film quality improver being one or more selected form the group consisting of 2-chloro-2-methylpropane, 2-chloro-2-methylbutane etc (limitation of step i-a), however, Chemical Formula 1 as defined in the claim includes a much broader group of chemical compounds than the list “2-chloro-2-methylpropane, 2-chloro-2-methylbutane etc” in step i-a, for example, Chemical Formula 1 includes A as silicon, but none of the listed chemical compound in step i-a comprises silicon. Thus, it is unclear if the claim is intended to include all the possible compounds as defined by Chemical Formula 1, or just the listed compounds in step i-a as the quality improver. In addition, step 1-a defines the film quality improver being “a saturated compound represented by the following Chemical Formula 1” but also “one or more selected from the group consisting..”, thus, it is unclear if the film quality improver is limited to just one compound or “one or more”. For purpose of examination, the film quality improver is interpreted as the saturated compound represented by Chemical Formula 1. However, Applicant should clarify what is intended, without adding new matter. Specifically, remove one of the definitions for the film quality improver from the claim. Regarding claim 14, while the claim defines that the film quality improver being a saturated compound represented by Chemical Formula 1, it also defines that the film quality improver being one or more selected from form the group consisting of 2-chloro-2-methylpropane, 2-chloro-2-methylbutane etc (limitation of step iii-b), however, Chemical Formula 1 as defined in the claim includes a much broader group of chemical compounds than the list “2-chloro-2-methylpropane, 2-chloro-2-methylbutane etc” in step iii-b, for example, Chemical Formula 1 includes A as silicon, but none of the listed chemical compound in step i-a comprises silicon. Thus, it is unclear if the claim is intended to include all the possible compounds as defined by Chemical Formula 1, or just the listed compounds in step i-a as the quality improver. In addition, step iii-b defines the film quality improver being “a saturated compound represented by the following Chemical Formula 1” but also “one or more selected from the group consisting..”, thus, it is unclear if the film quality improver is limited to just one compound or “one or more”. For purpose of examination, the film quality improver is interpreted as a saturated compound represented by Chemical Formula 1. However, Applicant should clarify what is intended, without adding new matter. Specifically, remove one of the definitions for the film quality improver from the claim. Claim Rejections - 35 USC § 102 The claim rejections under 35 U.S.C. 102 (a)(1) as being anticipated by Yeon (KR102138149) on claims 6-8 and 14-16 are withdrawn, because the claims have been amended. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claims 6-8 and 14-16 are rejected under 35 U.S.C. 103 as being unpatentable over Yeon (KR102138149) in view of Dezelah (US20190003050). Regarding claim 6, Yeon teaches a method of forming a thin film (paragraph 0001) using a metal thin film precursor, wherein the metal is molybdenum (paragraph 0051). Thus, Yeon teaches the thin film comprises molybdenum (molybdenum based thin film). Yeon teaches to inject an inhibitor to the deposition chamber to be adsorbed on the surface of the substate (paragraphs 0017, 0046 and 0090), wherein the inhibitor facilitates to improve step coverage and thickness uniformity of the thin film being formed on a substate having complex structure (paragraph 0001), which reads on the limitation of film quality improver (injecting a film quality improver into a chamber and injecting the film quality improver onto a surface of a loaded substrate). Yeon teaches the inhibitor comprises the structure of AnBmXo, wherein A is carbon or silicon, X is halogen (F, Cl, Br or I), B is hydrogen or alkyl having 1 to 3 carbon atoms, n is an integer of 1, o is an integer 1, and m is 2n+1 (paragraphs 0015-0016), which reads on the claimed limitation of Chemical Formula 1 (A is carbon or silicon, B is hydrogen or alkyl having 1 to 3 carbon atoms, C is halogen, n is 1, o is 1 and m is 3), Yeon further teaches the specific example of the inhibitor is 2-chloro-2-methylbutane (paragraph 0034). Yeon teaches to vaporize the inhibitor to form a protected area (shield area) on the surface of the substrate in the chamber (paragraphs 0083, 0046, 0103, figure 2) (step i-a). Yeon teaches to performing first purge of an inside of the chamber using a purge gas (paragraphs 0046, figure 2) (step ii-a), vaporizing thin film precursor (molybdenum precursor) and adsorbing the precursor to an area outside the shielding area (figure 2, paragraphs 0083 and 0046) (step iii-a), performing second purging of the inside of the chamber using the purge gas (paragraph 0046, figure 2) (step iv-2), supplying a reaction gas into the chamber (step v-a) and performing third purging of the inside of the chamber using the purge gas (step vi-a) to form the thin film on the surface of the substate (step vii-a) (molybdenum based thin film) (paragraphs 0103, 0046, 0051, see figure 2). Some of the recitations in Yeon uses Ti as example but would be clear to one of the ordinary skill in the art that the steps and method are applicable to all other thin film precursor as recited in paragraph 0051, including molybdenum, as Yeon’s general teaching is directed to other metal based films, including molybdenum. Yeon teaches the thin film is a metal oxide, metal nitride film (paragraphs 0004, 0051-0053), and the metal is molybdenum (paragraph 0051) (the thin film comprises molybdenum oxide, molybdenum nitride). Yeon teaches the molybdenum-based thin film is deposited by atomic vapor deposition (ALD) and the metal precursor can be metal carbonyl compound (paragraph 0051-0052), but does not explicitly teaches the claimed molybdenum precursor (Chemical Formula 2 to 36). However, Dezelah teaches a method of preparing molybdenum thin film by ALD (paragraph 0001), wherein the molybdenum film includes molybdenum nitride or molybdenum oxide (paragraph 0059). Dezelah teaches the molybdenum precursor is carbonyl compound with formula PNG media_image2.png 146 154 media_image2.png Greyscale with R1 and R2 and R3 being Cl or methyl and M being Mo (paragraph 0011), which reads on the claimed molybdenum precursor PNG media_image3.png 110 110 media_image3.png Greyscale . It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to use the molybdenum precursor for ALD a molybdenum nitride of oxide film as suggested by Dezelah in the method of Yeon so that the film quality improver is for the molybdenum carbonyl compound as a precursor compound being used to form the molybdenum-based thin film because Dezelah teaches such precursor has improved thermal stability, higher volatility, increased vapor pressure, and increased deposition rates for the ALD (paragraph 0010). Regarding claim 7, Yeon teaches the thin film is a metal oxide, metal nitride film (paragraphs 0004, 0051-0053), and the metal is molybdenum (paragraph 0051). Dezelah teaches thin film includes molybdenum nitride or molybdenum oxide (paragraph 0059). Regarding claim 8, Yeon teaches the inhibitor is transferred into the atomic layer deposition (ALD) chamber by vapor flow control (VFC) or LDS (liquid delivery system) method (paragraphs 0048 and 0093). Regarding claim 14, Yeon teaches a method of forming a thin film (paragraph 0001) using a metal thin film precursor, wherein the metal is molybdenum (paragraph 0051). Thus, Yeon teaches the thin film comprises molybdenum (molybdenum based thin film). Yeon teaches to inject an inhibitor to the deposition chamber to be adsorbed on the surface of the substate (paragraphs 0017, 0046 and 0090), wherein the inhibitor facilitates to improve step coverage and thickness uniformity of the thin film being formed on a substate having complex structure (paragraph 0001), which reads on the limitation of film quality improver (injecting a film quality improver into a chamber and injecting the film quality improver onto a surface of a loaded substrate). Yeon teaches the inhibitor comprises the structure of AnBmXo, wherein A is carbon or silicon, X is halogen (F, Cl, Br or I), B is hydrogen or alkyl having 1 to 3 carbon atoms, n is an integer of 1, o is an integer 1, and m is 2n+1 (paragraphs 0015-0016), which reads on the claimed limitation of Chemical Formula 1 (A is carbon or silicon, B is hydrogen or alkyl having 1 to 3 carbon atoms, C is halogen, n is 1, o is 1 and m is 3), Yeon further teaches the specific example of the inhibitor is 2-chloro-2-methylbutane (paragraph 0034). Yeon teaches to inject and vaporize a thin film precursor and adsorbing the precursor on the surface of the substrate in the chamber (molybdenum precursor) (paragraphs 0103, 0046, 0051, figure 2) (step i-b), Yeon teaches to perform first purge of an inside of the chamber using a purge gas (paragraph 0046, figure 2) (step ii-b). Yeon teaches to vaporize and inject the inhibitor onto the surface of the substrate in the chamber (paragraphs 0103 and 0046, figure 2) (step iii b), performing second purging of the inside of the chamber using the purge gas (paragraph 0046, figure 2) (iv-b). Yeon teaches to supply a reaction gas into the chamber (paragraph 0046, figure 2) (step v-b). Yeon teaches to perform third purging of the inside of the chamber using the purge gas (step vi-b) and forming the thin film (molybdenum based thin film) on the surface of the substate (step vii) (paragraphs 0103, 0046, 0051, see figure 2). Some of the recitations in Yeon use Ti as example but would be clear to one of the ordinary skill in the art that the steps and method are applicable to all other thin film precursor as recited in paragraph 0051, including molybdenum, as Yeon’s general teaching is directed to other metal based films, including molybdenum. Yeon teaches the thin film is a metal oxide, metal nitride film (paragraphs 0004, 0051-0053), and the metal is molybdenum (paragraph 0051) (the thin film comprises molybdenum oxide, molybdenum nitride). Yeon teaches the molybdenum-based thin film is deposited by atomic vapor deposition (ALD) (paragraph 0051) and the metal precursor can be metal carbonyl compound (paragraph 0051-0052), but does not explicitly teaches the claimed molybdenum precursor (Chemical Formula 2 to 36). However, Dezelah teaches a method of preparing molybdenum thin film by ALD (paragraph 0001), wherein the molybdenum film includes molybdenum nitride or molybdenum oxide (paragraph 0059). Dezelah teaches the molybdenum precursor is a carbonyl compound with formula PNG media_image2.png 146 154 media_image2.png Greyscale with R1 and R2 and R3 being Cl or methyl and M being Mo (paragraph 0011), which reads on the claimed molybdenum precursor PNG media_image3.png 110 110 media_image3.png Greyscale . It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to use the molybdenum precursor for ALD a molybdenum nitride of oxide film as suggested by Dezelah in the method of Yeon so that the film quality improver is for the molybdenum carbonyl compound as a precursor compound being used to form the molybdenum-based thin film because Dezelah teaches such precursor has improved thermal stability, higher volatility, increased vapor pressure, and increased deposition rates for the ALD (paragraph 0010). Regarding claim 15, Yeon teaches the thin film is a metal oxide, metal nitride film (paragraphs 0004, 0051-0053), and the metal is molybdenum (paragraph 0051). Dezelah teaches thin film includes molybdenum nitride or molybdenum oxide (paragraph 0059). Regarding claim 16, Yeon teaches the inhibitor is transferred into the atomic layer deposition (ALD) chamber by vapor flow control (VFC) or LDS (liquid delivery system) method (paragraphs 0048 and 0093). Double Patenting The nonstatutory double patenting rejection is based on a judicially created doctrine grounded in public policy (a policy reflected in the statute) so as to prevent the unjustified or improper timewise extension of the “right to exclude” granted by a patent and to prevent possible harassment by multiple assignees. A nonstatutory double patenting rejection is appropriate where the conflicting claims are not identical, but at least one examined application claim is not patentably distinct from the reference claim(s) because the examined application claim is either anticipated by, or would have been obvious over, the reference claim(s). See, e.g., In re Berg, 140 F.3d 1428, 46 USPQ2d 1226 (Fed. Cir. 1998); In re Goodman, 11 F.3d 1046, 29 USPQ2d 2010 (Fed. Cir. 1993); In re Longi, 759 F.2d 887, 225 USPQ 645 (Fed. Cir. 1985); In re Van Ornum, 686 F.2d 937, 214 USPQ 761 (CCPA 1982); In re Vogel, 422 F.2d 438, 164 USPQ 619 (CCPA 1970); In re Thorington, 418 F.2d 528, 163 USPQ 644 (CCPA 1969). A timely filed terminal disclaimer in compliance with 37 CFR 1.321(c) or 1.321(d) may be used to overcome an actual or provisional rejection based on nonstatutory double patenting provided the reference application or patent either is shown to be commonly owned with the examined application, or claims an invention made as a result of activities undertaken within the scope of a joint research agreement. See MPEP § 717.02 for applications subject to examination under the first inventor to file provisions of the AIA as explained in MPEP § 2159. See MPEP § 2146 et seq. for applications not subject to examination under the first inventor to file provisions of the AIA . A terminal disclaimer must be signed in compliance with 37 CFR 1.321(b). The filing of a terminal disclaimer by itself is not a complete reply to a nonstatutory double patenting (NSDP) rejection. A complete reply requires that the terminal disclaimer be accompanied by a reply requesting reconsideration of the prior Office action. Even where the NSDP rejection is provisional the reply must be complete. See MPEP § 804, subsection I.B.1. For a reply to a non-final Office action, see 37 CFR 1.111(a). For a reply to final Office action, see 37 CFR 1.113(c). A request for reconsideration while not provided for in 37 CFR 1.113(c) may be filed after final for consideration. See MPEP §§ 706.07(e) and 714.13. The USPTO Internet website contains terminal disclaimer forms which may be used. Please visit www.uspto.gov/patent/patents-forms. The actual filing date of the application in which the form is filed determines what form (e.g., PTO/SB/25, PTO/SB/26, PTO/AIA /25, or PTO/AIA /26) should be used. A web-based eTerminal Disclaimer may be filled out completely online using web-screens. An eTerminal Disclaimer that meets all requirements is auto-processed and approved immediately upon submission. For more information about eTerminal Disclaimers, refer to www.uspto.gov/patents/apply/applying-online/eterminal-disclaimer. Claims 6-8 and 14-16 rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-15 of U.S. Patent No. 11746411 in view of Yeon (KR102138149) and Dezelah (US20190003050). Claims 6-8 and 14-16 overlaps with claims 1-12 of U.S. Patent No. 11746411, except the film is Ti based film and the Mo precursor. The first purging, second purging and supplying a reaction gas into the chamber are overlapped with the dependent claims of U.S. Patent No. 11746411. However, titanium and molybdenum in forming ALD thin film using inhibitor are considered as functionally equivalent as evidenced thin film material by Yeon (paragraph 0051). Therefore, it would have been obvious to one of ordinary skill in the art to substitute molybdenum for titanium as the thin film material in the method as disclosed claims 6-8 and 14-16. In addition, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to use the molybdenum precursor (same as the claimed precursor, see 103 rejection above) for ALD a molybdenum nitride of oxide film as suggested by Dezelah in the method of claims 1-12 of U.S. Patent No. 11746411 in view of Yeon because Dezelah teaches such precursor has improved thermal stability, higher volatility, increased vapor pressure, and increased deposition rates for the ALD (paragraph 0010). Claims 6-8 and 14-16 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-11 of U.S. Patent No.12252788 in view of Dezelah (US20190003050). Claims 6-8 and 14-16 overlaps with the scope of claims 1-11 U.S. Patent No.12252788, except the molybdenum precursor. The first purging, second purging and supplying a reaction gas into the chamber are overlapped with the dependent claims of U.S. Patent No. 12252788. However, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to use the molybdenum precursor (same as the claimed precursor, see 103 rejection above) for ALD a molybdenum nitride of oxide film as suggested by Dezelah in the method of claims 1-11 of U.S. Patent No.12252788 because Dezelah teaches such precursor has improved thermal stability, higher volatility, increased vapor pressure, and increased deposition rates for the ALD (paragraph 0010). Claims 6-8 and 14-16 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-5 of U.S. Patent No. 12421599 in view of Yeon (KR102138149) and Dezelah (US20190003050). Claims 6-8 and 14-16 overlaps with claims 1-5 of U.S. Patent No. 12421599 (tert-butyl bromide reads on chemical formula 1), except the film is molybdenum based film and the molybdenum precursor. The first purging, second purging and supplying a reaction gas into the chamber are overlapped with claim 2 of U.S. Patent No. 12421599. However, Yeon teaches molybdenum based film is the film material in forming ALD thin film using inhibitor as claimed (paragraph 0051). Therefore, it would have been obvious to one of ordinary skill in the art to form the molybdenum based thin film as suggested by Yeon in the method as disclosed by claims 1-15 of U.S. Patent No. 12421599 because Yeon teaches molybdenum based film is the film material in forming ALD thin film using inhibitor as claimed (paragraph 0051). However, it would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to use the molybdenum precursor (same as the claimed precursor, see 103 rejection above) for ALD a molybdenum nitride of oxide film as suggested by Dezelah in the method of claims 1-5 of U.S. Patent No. 12421599 in view of Yeon because Dezelah teaches such precursor has improved thermal stability, higher volatility, increased vapor pressure, and increased deposition rates for the ALD (paragraph 0010). Claims 6-8 and 14-16 are rejected on the ground of nonstatutory double patenting as being unpatentable over claims 1-6 of U.S. Patent No. 12448685 in view of Yeon (KR102138149) and Dezelah (US20190003050). Claims 6-8 and 14-16 overlaps with claims 1-6 of U.S. Patent No. 12448685 (the growth inhibitor reads on chemical formula 1), except the film is Mo based film and the Mo precursor. However, Yeon teaches molybdenum based film is the film material in forming ALD thin film using inhibitor as claimed (paragraph 0051). Therefore, it would have been obvious to one of ordinary skill in the art to form the molybdenum based thin film as suggested by Yeon in the method as disclosed by claims 1-6 of U.S. Patent No. 12448685 because Yeon teaches molybdenum based film is the film material in forming ALD thin film using inhibitor as claimed (paragraph 0051). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to use the molybdenum precursor (same as the claimed precursor, see 103 rejection above) for ALD a molybdenum nitride of oxide film as suggested by Dezelah in the method of claims 1-6 of U.S. Patent No. 12448685 in view of Yeon because Dezelah teaches such precursor has improved thermal stability, higher volatility, increased vapor pressure, and increased deposition rates for the ALD (paragraph 0010). Claims 6-8 and 14-16 are provisionally rejected on the ground of nonstatutory double patenting as being unpatentable over claims 7-15 of copending Application No. 18691435 in view of Yeon (KR102138149) and and Dezelah (US20190003050). Claims 6-8 and 14-16 overlaps with claims 7-15 of copending Application No. 18691435, except the film is Mo based film and the Mo precursor. However, Yeon teaches molybdenum based film is the film material in forming ALD thin film using inhibitor as claimed (paragraph 0051). Therefore, it would have been obvious to one of ordinary skill in the art to form the molybdenum based thin film as suggested by Yeon in the method as disclosed by claims 7-15 of copending Application No. 18691435 because Yeon teaches molybdenum based film is the film material in forming ALD thin film using inhibitor as claimed (paragraph 0051). It would have been obvious one of ordinary skill in the art to substitute molybdenum for titanium as the thin film material in the method as disclosed claims 6-8 and 14-16. It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to use the molybdenum precursor (same as the claimed precursor, see 103 rejection above) for ALD a molybdenum nitride of oxide film as suggested by Dezelah in the method of claims 7-15 of copending Application No. 18691435 in view of Yeon because Dezelah teaches such precursor has improved thermal stability, higher volatility, increased vapor pressure, and increased deposition rates for the ALD (paragraph 0010). This is a provisional nonstatutory double patenting rejection. Claims 6-8 and 14-16 are provisionally rejected on the ground of nonstatutory double patenting as being unpatentable over claims 7-13 and 16 of copending Application No. 18910856 in view of Yeon (KR102138149) and Dezelah (US20190003050). Claims 6-8 and 14-16 overlaps with claims 7-13 and 16 of copending Application No. 18910856 (the growth inhibitor reads on chemical formula 1), except the film is Mo based film and the Mo precursor. The first purging, second purging and supplying a reaction gas into the chamber are overlapped with claim 8 of Application No. 18910856. However, Yeon teaches molybdenum based film is the film material in forming ALD thin film using inhibitor as claimed (paragraph 0051). Therefore, it would have been obvious to one of ordinary skill in the art to form the molybdenum based thin film as suggested by Yeon in the method as disclosed by claims 7-13 and 16 of copending Application No. 18910856 because Yeon teaches molybdenum based film is the film material in forming ALD thin film using inhibitor as claimed (paragraph 0051). It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to use the molybdenum precursor (same as the claimed precursor, see 103 rejection above) for ALD a molybdenum nitride of oxide film as suggested by Dezelah in the method of claims 7-13 and 16 of copending Application No. 18910856 in view of Yeon because Dezelah teaches such precursor has improved thermal stability, higher volatility, increased vapor pressure, and increased deposition rates for the ALD (paragraph 0010). This is a provisional nonstatutory double patenting rejection. Claims 6-8 and 14-16 are provisionally rejected on the ground of nonstatutory double patenting as being unpatentable over claims 7-13 and 16-18 of copending Application No. 18950715 view of Yeon (KR102138149) and Dezelah (US20190003050). Claims 6-8 and 14-16 overlaps with 7-13 and 16-18 of copending Application No. 18950715 (the growth inhibitor reads on chemical formula 1), except the film is Mo based film and the Mo precursor. The first purging, second purging and supplying a reaction gas into the chamber are overlapped with claim 8 of Application No. 18950715. However, Yeon teaches molybdenum based film is the film material in forming ALD thin film using inhibitor as claimed (paragraph 0051). Therefore, it would have been obvious to one of ordinary skill in the art to form the molybdenum based thin film as suggested by Yeon in the method as disclosed by claims 7-13 and 16-18 of copending Application No. 18950715 because Yeon teaches molybdenum based film is the film material in forming ALD thin film using inhibitor as claimed (paragraph 0051).one of ordinary skill in the art to substitute molybdenum for titanium as the thin film material in the method as disclosed claims 6-8 and 14-16. It would have been obvious to one of ordinary skill in the art before the effective filing date of the claimed invention to use the molybdenum precursor (same as the claimed precursor, see 103 rejection above) for ALD a molybdenum nitride of oxide film as suggested by Dezelah in the method of claims 7-13 and 16-18 of copending Application No. 18950715 in view of Yeon because Dezelah teaches such precursor has improved thermal stability, higher volatility, increased vapor pressure, and increased deposition rates for the ALD (paragraph 0010). This is a provisional nonstatutory double patenting rejection. Response to Arguments Applicant's arguments filed on August 14, 2026 have been fully considered but they are not persuasive. Applicant’s principal arguments are: Yeon manufactured a TiN thin film or SiN thin film as shown in Table 2 of Examples 1 to 7, with titanium tetrahalides as preferred thin film precursor compounds. Yeon provides the thin film with reduced by-products and impurities while reducing the deposition rate, while the claimed molybdenum containing thin film with an increased deposition rate. Thus, Yeon thin film is different from the claimed invention. Yeon does not teach the new limitations. In response to Applicant’s arguments, please consider the following comments: Yeon clearly teaches the method is applicable to other metal, such as molybdenum, using metal precursor such as metal carbonyl compound (paragraph 0052). It is well settled that nonpreferred and alternative embodiments constitute prior art and disclosed examples and preferred embodiments do not constitute a teaching away from a broader disclosure or nonpreferred embodiments (see MPEP 2123 II). Thus, the examples of forming TiN does not renders the claimed invention distinct from Yeon. New reference Dezelah teaches the claimed molybdenum precursor. In response to applicant's argument that the references fail to show certain features of the invention, it is noted that the features upon which applicant relies (i.e., reducing/increasing by products and impurities, increasing/decreasing deposition rate) are not recited in the rejected claim(s). Although the claims are interpreted in light of the specification, limitations from the specification are not read into the claims. See In re Van Geuns, 988 F.2d 1181, 26 USPQ2d 1057 (Fed. Cir. 1993). New reference Dezelah teaches the new limitations, molybdenum precursor. Yeon teaches other limitations, including the film quality improver as claimed (see rejections above). Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to NGA LEUNG V LAW whose telephone number is (571)270-1115. The examiner can normally be reached M-F 8 am - 5 pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Dah-Wei Yuan can be reached at 5712721295. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /NGA LEUNG V LAW/Examiner, Art Unit 1717
Read full office action

Prosecution Timeline

Show 2 earlier events
Dec 04, 2025
Response Filed
Mar 27, 2026
Final Rejection mailed — §102, §103, §112
May 06, 2026
Response after Non-Final Action
May 15, 2026
Request for Continued Examination
May 20, 2026
Response after Non-Final Action
Jun 17, 2026
Non-Final Rejection mailed — §102, §103, §112
Aug 14, 2026
Response Filed
Nov 10, 2026
Final Rejection mailed — §102, §103, §112 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12802929
ENHANCED DEPOSITION RATE BY APPLYING A NEGATIVE VOLTAGE TO A GAS INJECTION NOZZLE IN FIB SYSTEMS
4y 1m to grant Granted Nov 17, 2026
Patent 12790678
MASK ASSEMBLY, AND APPARATUS AND METHOD OF MANUFACTURING DISPLAY APPARATUS
5y 11m to grant Granted Nov 10, 2026
Patent 12790948
Hybrid Thermal Barrier Coating
4y 5m to grant Granted Nov 10, 2026
Patent 12774247
METHOD FOR MANUFACTURING OPTICAL FIBER
3y 8m to grant Granted Oct 27, 2026
Patent 12768051
METHODS FOR INFILTRATING GALLIUM INTO POROUS SCAFFOLDS
2y 8m to grant Granted Oct 20, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

5-6
Expected OA Rounds
56%
Grant Probability
75%
With Interview (+18.3%)
3y 2m (~8m remaining)
Median Time to Grant
High
PTA Risk
Based on 558 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month